Top compounds associated with response to CCDC7


Feature Type Standardized
Nominal ANOVA
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA AT7867 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.073 0.02
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.079 0.02
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.08 0.02
mRNA PF-543 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.17 0.02
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.08 0.02
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
Download CSV